194 related articles for article (PubMed ID: 22711886)
21. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.
Habelhah H; Takahashi S; Cho SG; Kadoya T; Watanabe T; Ronai Z
EMBO J; 2004 Jan; 23(2):322-32. PubMed ID: 14713952
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.
Hostager BS; Haxhinasto SA; Rowland SL; Bishop GA
J Biol Chem; 2003 Nov; 278(46):45382-90. PubMed ID: 12958312
[TBL] [Abstract][Full Text] [Related]
23. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.
Lee SY; Reichlin A; Santana A; Sokol KA; Nussenzweig MC; Choi Y
Immunity; 1997 Nov; 7(5):703-13. PubMed ID: 9390693
[TBL] [Abstract][Full Text] [Related]
24. Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells.
Paiva C; Godbersen JC; Soderquist RS; Rowland T; Kilmarx S; Spurgeon SE; Brown JR; Srinivasa SP; Danilov AV
PLoS One; 2015; 10(11):e0143685. PubMed ID: 26606677
[TBL] [Abstract][Full Text] [Related]
25. SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
Paiva C; Rowland TA; Sreekantham B; Godbersen C; Best SR; Kaur P; Loriaux MM; Spurgeon SEF; Danilova OV; Danilov AV
Haematologica; 2017 Nov; 102(11):1890-1900. PubMed ID: 28838991
[TBL] [Abstract][Full Text] [Related]
26. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K.
Benson RJ; Hostager BS; Bishop GA
Eur J Immunol; 2006 Sep; 36(9):2535-43. PubMed ID: 16897814
[TBL] [Abstract][Full Text] [Related]
27. B cells generated by B-1 development can progress to chronic lymphocytic leukemia.
Hayakawa K; Formica AM; Colombo MJ; Ichikawa D; Shinton SA; Brill-Dashoff J; Hardy RR
Ann N Y Acad Sci; 2015 Dec; 1362():250-5. PubMed ID: 25907284
[TBL] [Abstract][Full Text] [Related]
28. Histogenesis and pathogenesis of follicular small cleaved cell lymphoma (FSCCL), diffuse small cleaved cell lymphoma (DSCCL) and intermediate lymphocytic lymphoma/lymphocytic lymphoma of intermediate differentiation (ILL/IDL).
Abe M; Wakasa H
Fukushima J Med Sci; 1994 Dec; 40(2):85-101. PubMed ID: 7642169
[TBL] [Abstract][Full Text] [Related]
29. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
30. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism.
Harlin H; Podack E; Boothby M; Alegre ML
J Immunol; 2002 Sep; 169(5):2451-9. PubMed ID: 12193714
[TBL] [Abstract][Full Text] [Related]
31. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies.
Zapata JM; Krajewska M; Krajewski S; Kitada S; Welsh K; Monks A; McCloskey N; Gordon J; Kipps TJ; Gascoyne RD; Shabaik A; Reed JC
J Immunol; 2000 Nov; 165(9):5084-96. PubMed ID: 11046039
[TBL] [Abstract][Full Text] [Related]
32. TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis.
Blackwell K; Zhang L; Thomas GS; Sun S; Nakano H; Habelhah H
Mol Cell Biol; 2009 Jan; 29(2):303-14. PubMed ID: 18981220
[TBL] [Abstract][Full Text] [Related]
33. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
Zarnegar BJ; Wang Y; Mahoney DJ; Dempsey PW; Cheung HH; He J; Shiba T; Yang X; Yeh WC; Mak TW; Korneluk RG; Cheng G
Nat Immunol; 2008 Dec; 9(12):1371-8. PubMed ID: 18997794
[TBL] [Abstract][Full Text] [Related]
34. Somatic mutation and memory.
Berek C
Curr Opin Immunol; 1993 Apr; 5(2):218-22. PubMed ID: 8507399
[TBL] [Abstract][Full Text] [Related]
35. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.
Li Z; Wang H; Xue L; Shin DM; Roopenian D; Xu W; Qi CF; Sangster MY; Orihuela CJ; Tuomanen E; Rehg JE; Cui X; Zhang Q; Morse HC; Morris SW
Blood; 2009 Nov; 114(19):4158-68. PubMed ID: 19696203
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis.
Sic H; Kraus H; Madl J; Flittner KA; von Münchow AL; Pieper K; Rizzi M; Kienzler AK; Ayata K; Rauer S; Kleuser B; Salzer U; Burger M; Zirlik K; Lougaris V; Plebani A; Römer W; Loeffler C; Scaramuzza S; Villa A; Noguchi E; Grimbacher B; Eibel H
J Allergy Clin Immunol; 2014 Aug; 134(2):420-8. PubMed ID: 24679343
[TBL] [Abstract][Full Text] [Related]
37. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.
Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF
J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096
[TBL] [Abstract][Full Text] [Related]
38. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
39. TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.
Chen Z; Krinsky A; Woolaver RA; Wang X; Chen SMY; Popolizio V; Xie P; Wang JH
J Immunol; 2020 Aug; 205(3):830-841. PubMed ID: 32591397
[TBL] [Abstract][Full Text] [Related]
40. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
